Application of dermal microdialysis for the determination of bioavailability of clobetasol propionate applied to the skin of human subjects

Skin Pharmacology and Physiology

Volumn 25, Issue 1, 2011, Pages 17-24

  Au, W L ^a   Skinner, M F ^a   Benfeldt, E ^b   Verbeeck, R K ^a,c   Kanfer, I ^a  

^a RHODES UNIVERSITY   (South Africa)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Bioavailability; Clobetasol propionate; Dermal microdialysis; Intralipid ; Topical application

Indexed keywords

CLOBETASOL PROPIONATE; INTRALIPID; LIPID EMULSION;

ADULT; ARTICLE; BIOEQUIVALENCE; DERMAL MICRODIALYSIS; DRUG BIOAVAILABILITY; DRUG PENETRATION; FEMALE; FOREARM; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; MICRODIALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; VOLUNTEER;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADSORPTION; ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CLOBETASOL; FEMALE; GLUCOCORTICOIDS; HUMANS; LIPIDS; MALE; MICRODIALYSIS; SKIN; SKIN ABSORPTION; SODIUM CHLORIDE; YOUNG ADULT;

EID: 80051791234     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000330489     Document Type: Article

References (34)

1. Chaurasia CS, Müller M, Bashaw ED, Ben-feldt E, Bolinder J, Bullock R, Bungay PM, DeLange EC, Derendorf H, Elmquist WF, Hammarlund-Udenaes M, Joukhadar C, Kellogg DL Jr, Lunte CE, Nordstrom CH, Rollema H, Sawchuk RJ, Cheung BW, Shah VP, Stahle L, Ungerstedt U, Welty DF, Yeo H: AAPS-FDA workshop white paper: microdi-alysis principles, application and regulatory perspectives. Pharm Res 2007; 24:1014-1025. (Pubitemid 46675390)
2. Ungerstedt U: Measurement of neurotrans-mitter release by intracranial dialysis; in Marsden CA (ed): Measurement of Neu-rotransmitter Release in vivo. Chichester, John Wiley & Son Ltd., 1984, pp 81-105.
3. Petersen LJ, Kristensen JK, Bülow J: Micro-dialysis of the interstitial water space in human skin in vivo: quantitative measurement of cutaneous glucose concentrations. J Invest Dermatol 1992; 99: 357-360.
4. Anderson C, Andersson T, Andersson RG: In vivo microdialysis estimation of histamine in human skin. Skin Pharmacol 1992; 5:177-183.
5. Matsuyama K, Nakashima M, Nakaboh Y, Ichikawa M, Yano T, Satoh S: Application of in vivo microdialysis to transdermal absorption of methotrexate in rats. Pharm Res 1994; 11:684-686. (Pubitemid 24171763)
6. Anderson C, Andersson T, Molander M: Ethanol absorption across human skin measured by in vivo microdialysis technique. Acta Derm Venereol 1991; 71: 389-393.
7. Ault JM, Riley CM, Meltzer NM, Lunte CE: Dermal microdialysis sampling in vivo. Pharm Res 1994; 11:1631-1639. (Pubitemid 24339686)
8. Benfeldt E, Serup J: Effect of barrier perturbation on cutaneous penetration of salicylic acid in hairless rats: in vivo pharmacokinet-ics using microdialysis and non-invasive quantification of barrier function. Arch Dermatol Res 1999; 291:517-526. (Pubitemid 29484133)
9. Morgan CJ, Renwick AG, Friedmann PS: The role of stratum corneum and dermal mi-crovascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br J Dermatol 2003; 148: 434-443. (Pubitemid 36461321)
10. Klimowicz A, Farfal S, Bielecka-Grzela S: Evaluation of skin penetration of topically applied drugs in humans by cutaneous mi-crodialysis: acyclovir vs. salicylic acid. J Clin Pharm Ther 2007; 32:143-148. (Pubitemid 46449702)
11. Benfeldt E, Hansen SH, Vølund A, Menné T, Shah VP: Bioequivalence of topical formulations in humans: evaluation by dermal mi-crodialysis sampling and the dermatophar-macokinetic method. J Invest Dermatol 2007; 127:170-178. (Pubitemid 46005675)
12. Tettey-Amlalo RNO, Kanfer I, Skinner MF, Benfeldt E, Verbeeck RK: Application of dermal microdialysis for the evaluation of bio-equivalence of a ketoprofen topical gel. Eur J Pharm Sci 2009; 36:219-225.
13. Kreilgaard M: Ass essment of cutaneous drug delivery using microdialysis. Adv Drug De-liv Rev 2002; 54:S99-S121. (Pubitemid 35379957)
14. García Ortiz P, Hansen SH, Shah VP, Sonne J, Benfeldt E: Are marketed topical metroni-dazole creams bioequivalent? Evaluation by in vivo microdialysis sampling and tape stripping methodology. Skin Pharmacol Physiol 2010; 24:44-53.
15. Holmgaard R, Nielsen JB, Benfeldt E: Micro-dialysis sampling for investigations of bio-availability and bioequivalence of topically administered drugs: current state and future perspectives. Skin Pharmacol Physiol 2011; 23: 225-243.
16. Kanfer I: Strategies for the bioequivalence assessment of topical dermatological dosage forms. J Bioequiv Availab 2010; 2:102-110.
17. Groth L, García Ortiz P, Benfeldt E: Micro-dialysis methodology for sampling in the skin; in Serup J, Jemec GBE, Grove GL (eds): Handbook of Non-Invasive Methods and the Skin. Florida, CRC Press, 2006, pp 443-454.
18. Verbeeck RK: Blood microdialysis in phar-macokinetic and drug metabolism studies. Adv Drug Deliv Rev 2000; 45:217-228.
19. Plock N, Kloft C: Microdialysis-theoretical background and recent implementation in applied life-sciences. Eur J Pharm Sci 2005; 25: 1-24. (Pubitemid 40602191)
20. Benfeldt E, Groth L: Feasibility of measuring lipophilic or protein-bound drugs in the der-mis by in vivo microdialysis after topical or systemic drug administration. Acta Derm Venereol 1998; 78:274-278. (Pubitemid 28328921)
21. Davies MI, Cooper JD, Desmond SS, Lunte CE, Lunte SM: Analytical considerations for microdialysis sampling. Adv Drug Deliv Rev 2000; 45: 169-188.
22. Groth L, Jørgensen A: In vitro microdialysis of hydrophilic and lipophilic compounds. A nal Chim Acta 1997; 355: 75-83. (Pubitemid 27528812)
23. Mary S, Muret P, Makki S, Jourdant M, Belon JP, Kantelip JP, Henry JC, Humbert P: Assessment of the recovery of three lipophilic psoralens by microdialysis: an in vitro study. Int J Pharm 1998; 161:7-13. (Pubitemid 28080653)
24. Fitzpatrick Skin Typing Test. http://www.la-fuentemedspa.com/The- Fitzpatrick-Skin. pdf.
25. Kellogg DL, Zhao JL, Wu Y: Neuronal nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo. J Physiol 2008; 586:847-857. (Pubitemid 351194122)
26. FDA: Guidance for industry: bioanalytical method validation. MD, USA, Center for Drug Evaluation and Research, Food and Drug Administration, 2001.
27. Kurosaki Y, Nakamura S, Shiojiri Y, Kawasaki H: Lipo-microdialysis: a new microdi-alysis method for studying the pharmacoki-netics of lipophilic substances. Biol Pharm Bull 1998; 21: 194-196. (Pubitemid 28120156)
28. Carneheim C, Ståhle L: Microdialysis of li-pophilic compounds: a methodological study. Pharmacol Toxicol 1991; 69: 378-380.
29. Kanfer I, Tettey-Amlalo RNO, Au WL, Hughes-Formella B: Assessment of topical dosage forms intended for local or regional activity; in Shargel L, Kanfer I (eds): Generic Drug Product Development-Specialty Dosage Forms. New York, Informa Healthcare USA, Inc., 2010, pp 75-88.
30. Borg N, Gotharson E, Benfeldt E, Groth L, Stahle L: Distribut ion to the skin of penciclo-vir after oral famciclovir administration in healthy volunteers: comparison of the suction blister technique and cutaneous micro-dia lysis. Acta Derm Venereol 1999; 79: 274-277. (Pubitemid 29302053)
31. Clough GF, Boutsiouki P, Church MK, Michel CC: Effects of blood flow on the in vivo recovery of a small diffusible molecule by microdialysis in human skin. J Pharmacol Exp Ther 2002; 302: 681-686. (Pubitemid 34787236)
32. Rojas C, Nagaraja N V, Derendorf H: In vitro recovery of triamcinolone acetonide in microdialysis. Pharmazie 2000; 55: 659-662.
33. Gattu S, Maibach HI: Modest but increased penetration through damaged skin: an over-v iew of the in vivo human model. Skin Pharmacol Physiol 2011; 24:2-9.
34. Tettey-Amlalo RNO: Application of Dermal Microdialysis and Tape Stripping Methods to Determine the Bioavailability and/or Bio-equivalence of Topical Ketoprofen Formulations; thesis/dissertation, Rhodes University, Grahamstown, 2008.